{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T02:12:36Z","timestamp":1792980756657,"version":"4.5.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100019592","name":"University of Nicosia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100019592","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose of Review<\/jats:title>\n            <jats:p>Colorectal cancer is the third most prevalent cancer globally and the second leading cause of cancer-related mortality. It typically develops over years through the progression of benign polyps to malignancy, driven by genetic alterations\u2014either spontaneous or inherited. This review summarizes current knowledge on colorectal cancer, including its epidemiology, risk factors, diagnostic methods, treatment strategies, preventative measures, and research developments, while identifying knowledge gaps to guide future studies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent Findings<\/jats:title>\n            <jats:p>Colorectal cancer is influenced by numerous lifestyle-related risk factors, such as high-calorie diets, processed foods, red meat, smoking, obesity, and alcohol use. Colonoscopy, imaging tests, and biopsies remain essential for diagnosis, while the TNM staging system continues to guide therapeutic decisions. Treatment options range from early-stage surgical interventions to chemotherapy, radiotherapy, and targeted therapies in advanced stages, with neoadjuvant and adjuvant treatments offering improved outcomes. Experimental therapies, including regorafenib and cancer vaccines, are under investigation. Prevention strategies focus on healthy lifestyles and risk avoidance, alongside screening techniques including fecal occult blood tests, colonoscopy, and sigmoidoscopy. Screening programs emphasize individuals with genetic susceptibility, and clinical trials aim to enhance both screening and therapeutic approaches.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Colorectal cancer poses a substantial global health challenge. Advances in diagnostics, treatment, and prevention are promising, but further research is needed to improve management strategies and address gaps in screening. Lifestyle changes and early detection through targeted screening remain critical for reducing the disease burden worldwide.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s11912-025-01707-w","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T02:32:14Z","timestamp":1754706734000},"page":"1115-1130","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Navigating the Colorectal Cancer Maze: Unveiling Pathways To Diagnosis, Management, Pathophysiology and Prevention"],"prefix":"10.1007","volume":"27","author":[{"given":"Khalid Ali Mohammed","family":"Al Kamzari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6167-4023","authenticated-orcid":false,"given":"Constantina","family":"Constantinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,9]]},"reference":[{"issue":"3","key":"1707_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3322\/caac.21772","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73(3):233\u201354. https:\/\/doi.org\/10.3322\/caac.21772.","journal-title":"CA Cancer J Clin"},{"key":"1707_CR2","unstructured":"World Health Organization Colorectal cancer. (accessed on December 20, 2024). Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/colorectal-cancer"},{"issue":"6369","key":"1707_CR3","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1126\/science.aal5240","volume":"358","author":"S Bullman","year":"2017","unstructured":"Bullman S, Pedamallu CS, Sicinska E, Clancy TE, Zhang X, Cai D, et al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science. 2017;358(6369):1443\u20138. https:\/\/doi.org\/10.1126\/science.aal5240.","journal-title":"Science"},{"issue":"7802","key":"1707_CR4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41586-020-2080-8","volume":"580","author":"C Pleguezuelos-Manzano","year":"2020","unstructured":"Pleguezuelos-Manzano C, Puschhof J, Rosendahl Huber A, van Hoeck A, Wood HM, Nomburg J, Gurjao C, et al. Mutational signature in colorectal cancer caused by genotoxic pks\u207a E. coli. Nature. 2020;580(7802):269. https:\/\/doi.org\/10.1038\/s41586-020-2080-8.","journal-title":"Nature"},{"issue":"10","key":"1707_CR5","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.annonc.2020.06.022","volume":"31","author":"G Argiles","year":"2020","unstructured":"Argiles G, Tabernero J, Labianca R, Hochhauser D, Salazar R, Iveson T, et al. Localised colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(10):1291\u2013305. https:\/\/doi.org\/10.1016\/j.annonc.2020.06.022.","journal-title":"Ann Oncol"},{"issue":"5","key":"1707_CR6","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1089\/lap.2022.0423","volume":"33","author":"K Kudou","year":"2023","unstructured":"Kudou K, Kusumoto T, Hasuda H, Tsuda Y, Kusumoto E, Uehara H, et al. Comparison of laparoscopic and open emergency surgery for colorectal perforation: A retrospective study. J Laparoendosc Adv Surg Tech. 2023;33(5):464\u201370. https:\/\/doi.org\/10.1089\/lap.2022.0423.","journal-title":"J Laparoendosc Adv Surg Tech"},{"key":"1707_CR7","unstructured":"Bruening W, Sullivan F, Paulson E, Zafar S, Mitchell E, Treadwell J et al. Imaging tests for the staging of colorectal cancer. Agency for Healthcare Research and Quality (US). 2014. Available from: http:\/\/www.ncbi.nlm.nih.gov"},{"key":"1707_CR8","doi-asserted-by":"publisher","unstructured":"Kuipers EJ, Grady WM, Lieberman D, Seufferlein T, Sung JJ, Boelens PG et al. Colorectal cancer. Nature Rev Dis Primers. 2015;1(1):15065. https:\/\/doi.org\/10.1038\/nrdp.2015.65. Available from: http:\/\/www.ncbi.nlm.nih.gov","DOI":"10.1038\/nrdp.2015.65"},{"key":"1707_CR9","doi-asserted-by":"crossref","unstructured":"Duan B, Zhao Y, Bai J, Wang J, Duan X, Luo X, Zhang R et al. Colorectal cancer: an overview. Exon Publications; 2022:1\u20132.","DOI":"10.36255\/exon-publications-gastrointestinal-cancers-colorectal-cancer"},{"key":"1707_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12875-021-01452-6","volume":"22","author":"K Holtedahl","year":"2021","unstructured":"Holtedahl K, Borgquist L, Donker GA, Buntinx F, Weller D, Campbell C, et al. Symptoms and signs of colorectal cancer, with differences between proximal and distal colon cancer: a prospective cohort study of diagnostic accuracy in primary care. BMC Fam Pract. 2021;22:1\u20133.","journal-title":"BMC Fam Pract"},{"issue":"11","key":"1707_CR11","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.4251\/wjgo.v11.i11.1011","volume":"11","author":"AR Syed","year":"2019","unstructured":"Syed AR, Thakkar P, Horne ZD, Abdul-Baki H, Kochhar G, Farah K, Thakkar S. Old vs new: risk factors predicting early onset colorectal cancer. World J Gastrointest Oncol. 2019;11(11):1011.","journal-title":"World J Gastrointest Oncol"},{"issue":"4","key":"1707_CR12","doi-asserted-by":"publisher","first-page":"415","DOI":"10.21147\/j.issn.1000-9604.2020.04.01","volume":"32","author":"National Health Commission of the People\u2019s Republic of China","year":"2020","unstructured":"National Health Commission of the People\u2019s Republic of China. National guidelines for diagnosis and treatment of colorectal cancer 2020 in China (English version). Chin J Cancer Res. 2020;32(4):415.","journal-title":"Chin J Cancer Res"},{"key":"1707_CR13","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1007\/s12094-015-1434-4","volume":"17","author":"E Aranda","year":"2015","unstructured":"Aranda E, Aparicio J, Alonso V, Garcia-Albeniz X, Garcia-Alfonso P, Salazar R, Valladares M, et al. SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer 2015. Clin Transl Oncol. 2015;17:972\u201381.","journal-title":"Clin Transl Oncol"},{"issue":"3","key":"1707_CR14","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1053\/j.gastro.2020.06.046","volume":"159","author":"CW Ko","year":"2020","unstructured":"Ko CW, Siddique SM, Patel A, Harris A, Sultan S, Altayar O, et al. AGA clinical practice guidelines on the Gastrointestinal evaluation of iron deficiency anemia. Gastroenterology. 2020;159(3):1085\u201394.","journal-title":"Gastroenterology"},{"issue":"5","key":"1707_CR15","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1055\/s-0031-1291717","volume":"44","author":"C Spada","year":"2012","unstructured":"Spada C, Hassan C, Galmiche JP, Neuhaus H, Dumonceau JM, Adler S, et al. Colon capsule endoscopy: European society of Gastrointestinal endoscopy (ESGE) guideline. Endoscopy. 2012;44(5):527\u201336.","journal-title":"Endoscopy"},{"issue":"18","key":"1707_CR16","doi-asserted-by":"publisher","first-page":"4570","DOI":"10.3390\/cancers15184570","volume":"15","author":"A Kasprzak","year":"2023","unstructured":"Kasprzak A. Prognostic biomarkers of cell proliferation in colorectal cancer (CRC): from immunohistochemistry to molecular biology techniques. Cancers. 2023;15(18):4570.","journal-title":"Cancers"},{"key":"1707_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13017-018-0209-9","volume":"13","author":"M Pisano","year":"2018","unstructured":"Pisano M, Zorcolo L, Merli C, Cimbanassi S, Poiasina E, Ceresoli M, Agresta F, et al. 2017 WSES guidelines on colon and rectal cancer emergencies: obstruction and perforation. World J Emerg Surg. 2018;13:1\u201327. https:\/\/doi.org\/10.1186\/s13017-018-0209-9.","journal-title":"World J Emerg Surg"},{"issue":"1","key":"1707_CR18","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s10462-021-09993-7","volume":"55","author":"C Yu","year":"2022","unstructured":"Yu C, Helwig EJ. The role of AI technology in prediction, diagnosis and treatment of colorectal cancer. Artif Intell Rev. 2022;55(1):323\u201343. https:\/\/doi.org\/10.1007\/s10462-021-09993-7.","journal-title":"Artif Intell Rev"},{"key":"1707_CR19","unstructured":"Ferlay J, Ervik M, Lam F, Colombet M, Mery L et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer; 2022. Available from: https:\/\/gco.iarc.fr\/today"},{"issue":"10125","key":"1707_CR20","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","volume":"391","author":"C Allemani","year":"2018","unstructured":"Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, et al. Global surveillance of trends in cancer survival 2000\u201314 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023\u201375. https:\/\/doi.org\/10.1016\/S0140-6736(17)33326-3.","journal-title":"Lancet"},{"issue":"2","key":"1707_CR21","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","volume":"72","author":"E Morgan","year":"2023","unstructured":"Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M, Vignat J, et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023;72(2):338\u201344.","journal-title":"Gut"},{"issue":"1","key":"1707_CR22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1053\/j.gastro.2020.03.054","volume":"159","author":"L Wang","year":"2020","unstructured":"Wang L, Lo CH, He X, Hang D, Wang M, Wu K, et al. Risk factor profiles differ for cancers of different regions of the colorectum. Gastroenterology. 2020;159(1):241\u201356.","journal-title":"Gastroenterology"},{"issue":"7","key":"1707_CR23","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/ng1834","volume":"38","author":"DJ Weisenberger","year":"2006","unstructured":"Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, et al. CpG Island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet. 2006;38(7):787\u201393.","journal-title":"Nat Genet"},{"issue":"6","key":"1707_CR24","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1053\/j.gastro.2010.01.054","volume":"138","author":"KW Jasperson","year":"2010","unstructured":"Jasperson KW, Tuohy TM, Neklason DW, Burt RW. Hereditary and Familial colon cancer. Gastroenterology. 2010;138(6):2044\u201358.","journal-title":"Gastroenterology"},{"issue":"1","key":"1707_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2353\/jmoldx.2008.070082","volume":"10","author":"S Ogino","year":"2008","unstructured":"Ogino S, Goel A. Molecular classification and correlates in colorectal cancer. J Mol Diagn. 2008;10(1):13\u201327.","journal-title":"J Mol Diagn"},{"issue":"9","key":"1707_CR26","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1056\/NEJM198809013190901","volume":"319","author":"B Vogelstein","year":"1988","unstructured":"Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319(9):525\u201332.","journal-title":"N Engl J Med"},{"issue":"2","key":"1707_CR27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0092-8674(00)81333-1","volume":"87","author":"KW Kinzler","year":"1996","unstructured":"Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996;87(2):159\u201370.","journal-title":"Cell"},{"issue":"3","key":"1707_CR28","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/sj.bjc.6602358","volume":"92","author":"AJ Munro","year":"2005","unstructured":"Munro AJ, Lain S, Lane DP. P53 abnormalities and outcomes in colorectal cancer: a systematic review. Br J Cancer. 2005;92(3):434\u201344.","journal-title":"Br J Cancer"},{"issue":"1","key":"1707_CR29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3390\/ijms18010197","volume":"18","author":"I M\u00e1rmol","year":"2017","unstructured":"M\u00e1rmol I, S\u00e1nchez-de-Diego C, Pradilla Dieste A, Cerrada E, Rodriguez Yoldi MJ. Colorectal carcinoma: a general overview and future perspectives in colorectal cancer. Int J Mol Sci. 2017;18(1):197.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1707_CR30","doi-asserted-by":"publisher","first-page":"276","DOI":"10.4132\/jptm.2020.04.15","volume":"54","author":"JH Kim","year":"2020","unstructured":"Kim JH, Kang GH. Evolving pathologic concepts of serrated lesions of the colorectum. J Pathol Transl Med. 2020;54(4):276\u201389.","journal-title":"J Pathol Transl Med"},{"issue":"4","key":"1707_CR31","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/1097-0142(19850815)56:4<939::AID-CNCR2820560440>3.0.CO;2-T","volume":"56","author":"HT Lynch","year":"1985","unstructured":"Lynch HT, Schuelke GS, Kimberling WJ, Albano WA, Lynch JF, Biscone KA, et al. Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). II. Biomarker studies. Cancer. 1985;56(4):939\u201351.","journal-title":"Cancer"},{"issue":"1","key":"1707_CR32","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1146\/annurev-pathol-011110-130235","volume":"6","author":"ER Fearon","year":"2011","unstructured":"Fearon ER. Molecular genetics of colorectal cancer. Annu Rev Pathol. 2011;6(1):479\u2013507.","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"1707_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humpath.2010.06.002","volume":"42","author":"DC Snover","year":"2011","unstructured":"Snover DC. Update on the serrated pathway to colorectal carcinoma. Hum Pathol. 2011;42(1):1\u201310.","journal-title":"Hum Pathol"},{"issue":"5","key":"1707_CR34","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3748\/wjg.v19.i5.607","volume":"19","author":"\u00c1V Patai","year":"2013","unstructured":"Patai \u00c1V, Moln\u00e1r B, Tulassay Z, Sipos F. Serrated pathway: alternative route to colorectal cancer. World J Gastroenterol. 2013;19(5):607.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"1707_CR35","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","volume":"61","author":"ER Fearon","year":"1990","unstructured":"Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61(5):759\u201367.","journal-title":"Cell"},{"key":"1707_CR36","unstructured":"National Institute for Health and Care Excellence. Colorectal cancer. (Accessed on December 20, 2024). Available from: http:\/\/www.nice.org.uk"},{"issue":"5","key":"1707_CR37","first-page":"43","volume":"18","author":"Y Al-Khazraji","year":"2024","unstructured":"Al-Khazraji Y, Muzammil MA, Javid S, Tangella AV, Gohil NV, Saifullah H, et al. Novel regimens and treatment strategies in neoadjuvant therapy for colorectal cancer: A systematic review. Int J Health Sci. 2024;18(5):43.","journal-title":"Int J Health Sci"},{"issue":"9","key":"1707_CR38","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.5306\/wjco.v15.i9.1136","volume":"15","author":"H Fadlallah","year":"2024","unstructured":"Fadlallah H, El Masri J, Fakhereddine H, Youssef J, Chemaly C, Doughan S, et al. Colorectal cancer: recent advances in management and treatment. World J Clin Oncol. 2024;15(9):1136.","journal-title":"World J Clin Oncol"},{"key":"1707_CR39","unstructured":"National Cancer Institute. Comprehensive Cancer Information \u2013 NCI. National Cancer Institute at the National Institutes of Health. (accessed on November 13, 2024). Available from: http:\/\/www.cancer.gov"},{"issue":"15","key":"1707_CR40","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1016\/j.ejca.2015.07.024","volume":"51","author":"B Holleczek","year":"2015","unstructured":"Holleczek B, Rossi S, Domenic A, Innos K, Minicozzi P, Francisci S, et al. On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999\u20132007\u2013results from the EUROCARE-5 study. Eur J Cancer. 2015;51(15):2158\u201368.","journal-title":"Eur J Cancer"},{"issue":"9","key":"1707_CR41","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S1470-2045(17)30422-9","volume":"18","author":"MJ Overman","year":"2017","unstructured":"Overman MJ, McDermott R, Leach JL, Lonardi S, Lenz HJ, et al. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. Lancet Oncol. 2017;18(9):1182\u201391. https:\/\/doi.org\/10.1016\/S1470-2045(17)30422-9.","journal-title":"Lancet Oncol"},{"issue":"14","key":"1707_CR42","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.7150\/ijbs.64077","volume":"17","author":"A Fan","year":"2021","unstructured":"Fan A, Wang B, Wang X, Nie Y, Fan D, Zhao X, et al. Immunotherapy in colorectal cancer: current achievements and future perspective. Int J Biol Sci. 2021;17(14):3837.","journal-title":"Int J Biol Sci"},{"issue":"11","key":"1707_CR43","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.1111\/cas.15961","volume":"114","author":"T Wang","year":"2023","unstructured":"Wang T, Liu W, Shen Q, Tao R, Li C, Shen Q, et al. Combination of PARP inhibitor and CDK4\/6 inhibitor modulates cGAS\/STING-dependent therapy\u2010induced senescence and provides one\u2010two punch opportunity with anti\u2010PD\u2010L1 therapy in colorectal cancer. Cancer Sci. 2023;114(11):4184\u2013201.","journal-title":"Cancer Sci"},{"key":"1707_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-020-01811-8","volume":"40","author":"PP Vitiello","year":"2021","unstructured":"Vitiello PP, Martini G, Mele L, Giunta EF, De Falco V, Ciardiello D, et al. Vulnerability to low-dose combination of Irinotecan and niraparib in ATM-mutated colorectal cancer. J Exp Clin Cancer Res. 2021;40:1\u20135.","journal-title":"J Exp Clin Cancer Res"},{"key":"1707_CR45","doi-asserted-by":"publisher","first-page":"1165666","DOI":"10.3389\/fphar.2023.1165666","volume":"14","author":"F Li","year":"2023","unstructured":"Li F, Lin Y, Li R, Shen X, Xiang M, Xiong G, et al. Molecular targeted therapy for metastatic colorectal cancer: current and evolving approaches. Front Pharmacol. 2023;14:1165666.","journal-title":"Front Pharmacol"},{"key":"1707_CR46","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.3389\/fimmu.2020.01624","volume":"11","author":"NA Johdi","year":"2020","unstructured":"Johdi NA, Sukor NF. Colorectal cancer immunotherapy: options and strategies. Front Immunol. 2020;11:1624.","journal-title":"Front Immunol"},{"key":"1707_CR47","doi-asserted-by":"publisher","first-page":"942235","DOI":"10.3389\/fimmu.2022.942235","volume":"13","author":"W Jia","year":"2022","unstructured":"Jia W, Zhang T, Huang H, Feng H, Wang S, Guo Z, et al. Colorectal cancer vaccines: the current scenario and future prospects. Front Immunol. 2022;13:942235.","journal-title":"Front Immunol"},{"key":"1707_CR48","unstructured":"Clinicaltrials.org. Assessment of Safety and Immunogenicity of Intradermal Electroporation of tetwtCEA DNA in Patients With Colorectal Cancer. National Library of Medicine, US. (); 2009 (accessed on January 6, 2025). Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01064375"},{"key":"1707_CR49","unstructured":"Clinicaltrials.org. Dendritic Cell Vaccination in Patients With Lynch Syndrome or Colorectal Cancer With MSI. National Library of Medicine (US); 2010;(accessed on January 6, 2025). Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01885702"},{"key":"1707_CR50","unstructured":"Clinicaltrials.org. Phase II Trial of Combination Immunotherapy in Subjects With Advanced Small Bowel and Colorectal Cancers. National Library of Medicine (US); 2020 (accessed on January 6, 2025). Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04491955"},{"key":"1707_CR51","unstructured":"Randomized Corg. Double-Blind, Placebo-Controlled Trial of MUC1 Vaccine in Patients With Newly Diagnosed Advanced Adenomas [Internet]. National Library of Medicine (US); 2014 (accessed on January 6, 2025). Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02134925"},{"key":"1707_CR52","unstructured":"Clinicaltrials.org. A Phase Ib\/II Clinical Trial of Nous-209 for Recurrent Neoantigen Immunogenicity and Cancer Immune Interception in Lynch Syndrome. National Library of Medicine (US); 2022 (accessed on January 6, 2025). Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05078866"},{"key":"1707_CR53","unstructured":"Phase CorgA. IIB Clinical Trial of the Multitargeted Recombinant Adenovirus 5 (CEA\/MUC1\/Brachyury) Vaccine (TRI-AD5) and IL-15 Superagonist N-803 in Lynch Syndrome [Internet]. National Library of Medicine (US); 2023 (accessed on January 6, 2025).Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05419011"},{"key":"1707_CR54","unstructured":"Clinicaltrials.org. A Multicenter Clinical Study of Personalized Tumor Neoantigen-based Peptide Vaccine Combined with Conventional Third-line Therapy for the Treatment of Colorectal Cancer Progressed After Second-line Treatment. National Library of Medicine (US); 2024 (accessed on January 6, 2025). Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT06751966"},{"key":"1707_CR55","unstructured":"Clinicaltrials.org. Clinical Translational Research on Personalized Cancer Vaccines Combined with Radiation Therapy [Internet]. National Library of Medicine (US); 2025 (accessed on January 6, 2025). Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT06756295"},{"key":"1707_CR56","unstructured":"Clinicaltrials.org. A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer. (accessed on July 12, 2025). Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04607421"},{"key":"1707_CR57","unstructured":"Kisling LA, Das JM, Prevention strategies. StatPearls. 2024 (accessed on February 18, 2025). Available from: https:\/\/www.statpearls.com"},{"issue":"5","key":"1707_CR58","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s13238-018-0543-6","volume":"9","author":"J Yang","year":"2018","unstructured":"Yang J, Yu J. The association of diet, gut microbiota and colorectal cancer: what we eat May imply what we get. Protein Cell. 2018;9(5):474\u201387. https:\/\/doi.org\/10.1007\/s13238-018-0543-6.","journal-title":"Protein Cell"},{"issue":"1","key":"1707_CR59","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1093\/ije\/dyz064","volume":"49","author":"KE Bradbury","year":"2020","unstructured":"Bradbury KE, Murphy N, Key TJ. Diet and colorectal cancer in UK biobank: a prospective study. Int J Epidemiol. 2020;49(1):246\u201358. https:\/\/doi.org\/10.1093\/ije\/dyz064.","journal-title":"Int J Epidemiol"},{"key":"1707_CR60","doi-asserted-by":"publisher","first-page":"CGast","DOI":"10.4137\/CGast.S14039","volume":"7","author":"PJ L\u00f3pez","year":"2014","unstructured":"L\u00f3pez PJ, Albero JS, Rodr\u00edguez-Montes JA. Primary and secondary prevention of colorectal cancer. Clin Med Insights: Gastroenterol. 2014;7:CGast\u2013S14039. https:\/\/doi.org\/10.4137\/CGast.S14039.","journal-title":"Clin Med Insights: Gastroenterol"},{"key":"1707_CR61","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/S0140-6736(10)60551-X","volume":"375","author":"A Ws","year":"2010","unstructured":"Ws A. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicenter randomized controlled trial. Lancet. 2010;375:1624\u201333. https:\/\/doi.org\/10.1016\/S0140-6736(10)60551-X.","journal-title":"Lancet"},{"issue":"8","key":"1707_CR62","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1002\/ijc.28840","volume":"135","author":"N Keum","year":"2014","unstructured":"Keum N, Aune D, Greenwood DC, Ju W, Giovannucci EL. Calcium intake and colorectal cancer risk: Dose\u2013response meta-analysis of prospective observational studies. Int J Cancer. 2014;135(8):1940\u20138. https:\/\/doi.org\/10.1002\/ijc.28840.","journal-title":"Int J Cancer"},{"issue":"10","key":"1707_CR63","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1002\/ijc.3029","volume":"139","author":"X Zhang","year":"2016","unstructured":"Zhang X, Keum N, Wu K, Smith-Warner, et al. Calcium intake and colorectal cancer risk: results from the nurses\u2019 health study and health professionals Follow-up study. Int J Cancer. 2016;139(10):2232\u201342. https:\/\/doi.org\/10.1002\/ijc.3029.","journal-title":"Int J Cancer"},{"issue":"12","key":"1707_CR64","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1158\/1055-9965.EPI-07-0708","volume":"16","author":"AA Moghaddam","year":"2007","unstructured":"Moghaddam AA, Woodward M, Huxley R. Obesity and risk of colorectal cancer: A meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev. 2007;16(12):2533\u201347. https:\/\/doi.org\/10.1158\/1055-9965.EPI-07-0708.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1707_CR65","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.14309\/ajg.0000000000002695","volume":"10","author":"S Nafisi","year":"2022","unstructured":"Nafisi S, St\u00f8er NC, Veier\u00f8d MB, Randel KR, Hoff G, L\u00f6fling L, et al. Low-dose aspirin and prevention of colorectal cancer: evidence from a nationwide registry-based cohort in Norway. Official J Am Coll Gastroenterol (ACG). 2022;10:4309. https:\/\/doi.org\/10.14309\/ajg.0000000000002695.","journal-title":"Official J Am Coll Gastroenterol (ACG)"},{"issue":"5","key":"1707_CR66","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1097\/00006250-199905000-00022","volume":"93","author":"K Nanda","year":"1999","unstructured":"Nanda K, Bastian LA, Hasselblad V, Simel DL. Hormone replacement therapy and the risk of colorectal cancer: A meta-analysis. Obstet Gynecol. 1999;93(5):880\u20138. https:\/\/doi.org\/10.1097\/00006250-199905000-00022.","journal-title":"Obstet Gynecol"},{"key":"1707_CR67","doi-asserted-by":"publisher","unstructured":"Brenner H, Chen C. (2018). The colorectal cancer epidemic: challenges and opportunities for primary, secondary, and tertiary prevention. British Journal of Cancer. 2018;119(7):785\u2013792. https:\/\/doi.org\/10.1038\/s41416-018-0211-9","DOI":"10.1038\/s41416-018-0211-9"},{"issue":"14","key":"1707_CR68","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1016\/j.ejca.2013.04.029","volume":"49","author":"H Brenner","year":"2013","unstructured":"Brenner H, Tao S. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy. Eur J Cancer. 2013;49(14):3049\u201354. https:\/\/doi.org\/10.1016\/j.ejca.2013.04.029.","journal-title":"Eur J Cancer"},{"issue":"5","key":"1707_CR69","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1053\/j.gastro.2017.02.001","volume":"152","author":"DJ Robertson","year":"2017","unstructured":"Robertson DJ, Lee JK, Boland CR, Dominitz et al. Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: A consensus statement by the US Multi-Society task force on colorectal cancer. Gastroenterology 2017;152(5):1217\u201337. doi:https:\/\/doi.org\/10.1053\/j.gastro.2017.02.001.","journal-title":"Gastroenterology"},{"issue":"2","key":"1707_CR70","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/ijc.31352","volume":"143","author":"A Gies","year":"2018","unstructured":"Gies A, Bhardwaj M, Stock C, Schrotz-King P, Brenner H. Quantitative fecal immunochemical tests for colorectal cancer screening. Int J Cancer. 2018;143(2):234\u201344. https:\/\/doi.org\/10.1002\/ijc.31352.","journal-title":"Int J Cancer"},{"key":"1707_CR71","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s12282-023-01414-wt","volume":"62","author":"CA Tanadi","year":"2024","unstructured":"Tanadi CA, Tandarto KE, Stella MM, Sutanto KW, Steffanus MA, Tenggara R, Bestari MB. Colorectal cancer screening guidelines for average-risk and high-risk individuals: A systematic review. Rom J Intern Med. 2024;62:101\u201323. https:\/\/doi.org\/10.1007\/s12282-023-01414-wt.","journal-title":"Rom J Intern Med"},{"key":"1707_CR72","doi-asserted-by":"publisher","unstructured":"Rozani S, Lykoudis PM. (2024). Overcoming geographical and socioeconomic limitations in colorectal cancer screening. World Journal of Gastrointestinal Oncology. 2024;16(5):1683. https:\/\/doi.org\/10.4254\/wjgo.v16.i5.1683","DOI":"10.4254\/wjgo.v16.i5.1683"},{"key":"1707_CR73","unstructured":"Clinicaltrials.org. The Efficiency of Colon Capsule Endoscopy in Colon Cancer Screening. National Library of Medicine (US); 2025 (accessed on January 8, 2025). Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03052335"},{"key":"1707_CR74","unstructured":"Clinicaltrials.org. Comparison Colon Capsule Endoscopy vs Optical Colonoscopy for Colorectal Cancer Screening in Familiar-Risk Population (CRIBADO). National Library of Medicine (US); 2025 (accessed on January 8, 2015). Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01557101"},{"key":"1707_CR75","unstructured":"Clinicaltrials.org. Prevention of Colorectal Cancer Through Multiomics Blood Testing (PREEMPT CRC). National Library of Medicine (US). 2025 (accessed on January 8, 2025). Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04369053"},{"key":"1707_CR76","unstructured":"Clinicaltrials.org. Colorectal Cancer Screening in Average-risk Population: Immunochemical Fecal Occult Blood Testing Versus Colonoscopy. National Library of Medicine (US); 2025 (accessed on January 8, 2025). Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00906997"},{"key":"1707_CR77","unstructured":"Clinicaltrials.org. A Cross-sectional Partnership to Improve Prevention. National Library of Medicine (US). 2025 (accessed on January 8, 2025). Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05903885"},{"issue":"6","key":"1707_CR78","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1001\/jamaoncol.2018.0126","volume":"4","author":"EL Van Blarigan","year":"2018","unstructured":"Van Blarigan EL, Fuchs CS, Niedzwiecki D, Zhang S, Saltz LB, Mayer RJ, et al. Association of survival with adherence to the American cancer society nutrition and physical activity guidelines for cancer survivors after colon cancer diagnosis: the CALGB 89803\/alliance trial. JAMA Oncol. 2018;4(6):783\u201390.","journal-title":"JAMA Oncol"},{"key":"1707_CR79","unstructured":"World Cancer Research Fund (WCRF). Diet, nutrition, physical activity and colorectal cancer: Continuous Update Project Expert Report. (accessed on January 8, 2025). Available from: https:\/\/www.wcrf.org"},{"key":"1707_CR80","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s11888-017-0386-1","volume":"13","author":"M Van Zutphen","year":"2017","unstructured":"Van Zutphen M, Kampman E, Giovannucci EL, van Duijnhoven FJ. Lifestyle after colorectal cancer diagnosis in relation to survival and recurrence: a review of the literature. Curr Colorectal Cancer Rep. 2017;13:370\u2013401. https:\/\/doi.org\/10.1007\/s11888-017-0386-1.","journal-title":"Curr Colorectal Cancer Rep"},{"issue":"6","key":"1707_CR81","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.3945\/ajcn.115.127092","volume":"103","author":"V Walter","year":"2016","unstructured":"Walter V, Jansen L, Ulrich A, Roth W, Bl\u00e4ker H, Chang-Claude J, Hoffmeister M, Brenner H. Alcohol consumption and survival of colorectal cancer patients: a population-based study from Germany. Am J Clin Nutr. 2016;103(6):1497\u2013506. https:\/\/doi.org\/10.3945\/ajcn.115.127092.","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"1707_CR82","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1136\/gutjnl-2015-309996","volume":"66","author":"HK Roy","year":"2017","unstructured":"Roy HK, Turzhitsky V, Wali R, Radosevich AJ, Jovanovic B, Della\u2019Zanna G, Umar A, Rubin DT, Goldberg MJ, Bianchi L, De La Cruz M. Spectral biomarkers for chemoprevention of colonic neoplasia: a placebo-controlled double-blinded trial with aspirin. Gut. 2017;66(2):285\u201392. https:\/\/doi.org\/10.1136\/gutjnl-2015-309996.","journal-title":"Gut"},{"issue":"9","key":"1707_CR83","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1136\/gutjnl-2014-308260","volume":"64","author":"P Li","year":"2015","unstructured":"Li P, Wu H, Zhang H, Shi Y, Xu J, Ye Y, et al. Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis. Gut. 2015;64(9):1419\u201325.","journal-title":"Gut"},{"issue":"3","key":"1707_CR84","doi-asserted-by":"publisher","first-page":"e0279784","DOI":"10.1371\/journal.pone.0279784","volume":"19","author":"KD Hoang","year":"2024","unstructured":"Hoang KD, Chen JH, Huang TW, Kang YN, Chen C, et al. Oral aspirin for preventing colorectal adenoma recurrence: A systematic review and network meta-analysis of randomized controlled trials. PLoS ONE. 2024;19(3):e0279784.","journal-title":"PLoS ONE"},{"issue":"14","key":"1707_CR85","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1001\/jama.2019.2402","volume":"321","author":"K Ng","year":"2019","unstructured":"Ng K, Nimeiri HS, McCleary NJ, Abrams TA, Yurgelun MB, Cleary JM, Rubinson DA, Schrag D, Allen JN, Zuckerman DS, Miksad RA. SUNSHINE: A randomized, double-blind, phase II trial of vitamin D supplementation in patients with previously untreated metastatic colorectal cancer. JAMA. 2019;321(14):1371\u20139. https:\/\/doi.org\/10.1001\/jama.2019.2402.","journal-title":"JAMA"},{"key":"1707_CR86","doi-asserted-by":"publisher","unstructured":"Kimball AB, Ravichandran S. Revisiting the SUNSHINE and SUNRISE trials. Lancet (London, England). 2024;403(10427):616. https:\/\/doi.org\/10.1016\/S0140-6736(23)02612-0","DOI":"10.1016\/S0140-6736(23)02612-0"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-025-01707-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11912-025-01707-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-025-01707-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:58:09Z","timestamp":1760144289000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11912-025-01707-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,9]]},"references-count":86,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["1707"],"URL":"https:\/\/doi.org\/10.1007\/s11912-025-01707-w","relation":{},"ISSN":["1534-6269"],"issn-type":[{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,9]]},"assertion":[{"value":"8 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}